Fed. Circ. Reverses Rejection Of Psoriasis Drug Patent

Law360, Los Angeles (November 22, 2013, 4:17 PM EST) -- The Federal Circuit on Friday overturned the U.S. Patent and Trademark Office's rejection of claims in an inventor's patent application for a psoriasis treatment, finding the office failed to support its findings that the claims were invalid as anticipated and obvious. 

A three-judge panel reversed the Patent Trial and Appeal Board's decision affirming a patent examiner's rejection of claims in Kevin P. Eaton's U.S. Patent Application 11,145,716, and remanded for further proceedings. In reversing the ruling, the Federal Circuit panel said the appeal board misconstrued a...
To view the full article, register now.